Evidence map›Paper›PMID 33434737›Full record

ArticleSchizophrenia research2021

Comparisons between suicide in persons with serious mental illness, other mental disorders, or no known mental illness: Results from 37 U.S. states, 2003-2017.

Timothy Schmutte, Mark Costa, Paul Hammer, Larry Davidson

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Timothy SchmutteDepartment of Psychiatry, Yale School of Medicine, Program for Recovery and Community Health, New Haven, CT, United States of America. Electronic address: timothy.schmutte@yale.edu.
Mark CostaDepartment of Psychiatry, Yale School of Medicine, Program for Recovery and Community Health, New Haven, CT, United States of America.
Paul HammerDepartment of Psychiatry, Yale School of Medicine, Program for Recovery and Community Health, New Haven, CT, United States of America.
Larry DavidsonDepartment of Psychiatry, Yale School of Medicine, Program for Recovery and Community Health, New Haven, CT, United States of America.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Improving the Emergency Department Management of Deliberate Self-HarmR01MH107452 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI MARCUS, STEVEN C, OLFSON, MARK · 2016 to 2020
$4.3M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH107452
6 · The paper itself

Abstract

backgroundSuicide is a leading cause of death in persons with schizophrenia and other serious mental illnesses (SMI), however, little is known about the characteristics and circumstances of suicide decedents with SMI in the US compared to those with other or no known mental illness.

methodsThis study was a retrospective analysis of suicide deaths in individuals aged ≥18 years from the National Violent Death Reporting System, 2003-2017. Odds ratios compared sociodemographic and clinical characteristics, cause of death, precipitating circumstances, and post-mortem toxicology results. All analyses were stratified by gender.

resultsOf the 174,001 suicide decedents, 8.7% had a known SMI, 33.0% had other mental disorders, and 58.2% had no known mental illness. Relative to persons with other mental disorders, SMI decedents were younger and more likely to have previous suicide attempts and co-occurring drug use. Problems with intimate partners, poor physical health, and recent institutional release were the most common precipitating circumstances for SMI decedents. Firearms were the most common suicide method for males with SMI. Although 67.0% male and 76.0% of female SMI decedents were currently in treatment, toxicology results suggest many were not taking antipsychotic or antidepressant medications at the time of death.

conclusionsPersons with SMI are over-represented in suicide deaths. Efforts to improve treatment of co-occurring substance use disorders, continuity of care following hospitalization, medication adherence, and to reduce access to firearms are important suicide prevention strategies.

Indexed as

Mental DisordersPopulation SurveillanceAdolescentAdultAge DistributionCause of DeathFemaleHumansMaleRetrospective StudiesSex DistributionUnited StatesLife eventsSchizophreniaSerious mental illnessSuicideToxicologyUnited States

Identifiers

PMID33434737
PMCPMC7987877
OpenAlexW3118650465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.